Kura Oncology (KURA) Gains from Investment Securities (2014 - 2025)
Kura Oncology (KURA) reported Gains from Investment Securities of $1.0 million for Q4 2025, down 92.14% year-over-year from $12.9 million in Q4 2024, and up 4.6% quarter-over-quarter from $969417.0 in Q3 2025.
Kura Oncology (KURA) Gains from Investment Securities (2014 - 2025) Analysis & Trends
Kura Oncology (KURA) has 12 years of Gains from Investment Securities data on file, last reported at $1.0 million in Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at $1.0 million, down 92.14% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.0 million (down 92.14% YoY), and the FY2025 annual result was $1.0 million, down 92.14% from the prior year.
- Gains from Investment Securities improved to $1.0 million in Q4 2025 per KURA's latest filing, from $969417.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $12.9 million in Q4 2024 and troughed at -$432000.0 in Q3 2021.
- A 5-year average of $2.3 million and a median of $991708.5 in 2025 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2021 and 2023: Gains from Investment Securities sank 156.25% in 2021, then soared 1010.79% in 2023.
- A 5-year view of Gains from Investment Securities shows it stood at $2.7 million in 2021, then sank by 66.03% to $927000.0 in 2022, then soared by 1010.79% to $10.3 million in 2023, then increased by 25.31% to $12.9 million in 2024, then slumped by 92.14% to $1.0 million in 2025.
- Business Quant data shows KURA's Gains from Investment Securities at $1.0 million in Q4 2025, $969417.0 in Q3 2025, and $1.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Kura Oncology | 883.44 Mn | 883.44 Mn | 18.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.01 Mn |
| Dec 31, 2025 | 1.01 Mn |
| Sep 30, 2025 | 969,417.00 |
| Sep 30, 2025 | 969,417.00 |
| Jun 30, 2025 | 1.16 Mn |
| Jun 30, 2025 | 1.16 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Dec 31, 2024 | 12.90 Mn |
| Dec 31, 2024 | 12.90 Mn |
| Dec 31, 2023 | 10.30 Mn |
| Dec 31, 2023 | 10.30 Mn |
| Dec 31, 2022 | 927,000.00 |
| Dec 31, 2022 | 927,000.00 |
| Sep 30, 2022 | -231,000.00 |
| Sep 30, 2022 | -231,000.00 |
| Jun 30, 2022 | 110,000.00 |
| Jun 30, 2022 | 110,000.00 |
| Mar 31, 2022 | -105,000.00 |
| Mar 31, 2022 | -105,000.00 |